Background: Many cases of refractory hypertension cannot be attributed to specific identifiable factors. Haptoglobin polymorphism has been suggested as a candidate genetic marker in essential hypertension. The aim of this study was to investigate the distribution of haptoglobin types in patients with refractory hypertension.
Methods: Haptoglobin polymorphism was studied in 363 patients with non-refractory and 62 patients with refractory hypertension. Haptoglobin was typed using starch gel electrophoresis of haemoglobin-supplemented serum.
Results: In the group of patients with refractory hypertension, the relative allele frequency of haptoglobin 1 (0.266) was lower than in the group with non-refractory hypertension (0.385; P < 0.05). The relative frequency of haptoglobin 2–2 was 39% in the non-refractory compared with 56% in the refractory group (P < 0.05). In the latter group, the relative frequency of haptoglobin 2–2 was highest (75%) in patients requiring medication with four classes of drug.
Conclusion: Hypertensive patients with the haptoglobin 2–2 phenotype are at higher risk of developing refractory hypertension than those with other haptoglobin phenotypes.
SetaroJBlackH: Refractory hypertension. N Engl J Med1992, 327: 543–547.
2.
WilliamsRHuntSHasstedtSHopkinsPWuLBerryT: Multigenic human hypertension: Evidence for subtypes and hope for haplotypes. J Hypertens1990, 8 (suppl 7):S39–S46.
3.
IsakssonHDanielssonMRosenhamerGKonarski-SvenssonJOstergrenJ: Characteristics of patients resistant to antihypertensive drug therapy. J Intern Med1991, 229: 421–426.
4.
DelangheJDuprezDDe BuyzereMBergezBCallensBLeroux-RoelsG: Haptoglobin polymorphism and complications in established essential arterial hypertension. J Hypertens1993, 11: 861–867.
5.
KuidaH: Genetics of hypertension: What we know and don't know. Clin Exp Hypertens [A]1990, 12: 865–876.
6.
WederASchorkNJuliusS: Linkage of MN locus and erythrocyte lithium-sodium countertransport in Tecumseh, Michigan. Hypertension1991, 17: 977–981.
7.
WeinbergerMMillerJFinebergNLuftFGrimCChristianJ: Association of haptoglobin with sodium sensitivity and resistance of blood pressure. Hypertension1987, 10: 443–446.
8.
MillerJWeinbergerMDaughertySFinebergNChristianJGrimC: Heterogeneity of blood pressure response to dietary sodium restriction in normotensive adults. J Chronic Dis1987, 40: 245–250.
9.
LuftFMillerJGrimCFinebergNChristianJDaughertyS: Salt sensitivity and resistance to blood pressure. Age and race as factors in physiological responses. Hypertension1991, 17 (suppl I):I102–I108.
10.
RocellaEJBowlerAEHoranM: Epidemiologic considerations in defining hypertension. Med Clin North Am1987, 71: 785–801.
SchillerNShahPCrawfordMDeMariaADevereuxRFeigenbaumH: Recommendations for quantitation of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography Committee on Standards Subcommittee. J Am Soc Echo1989, 2: 358–367.
13.
HarrisMHaddenWKnowlerWBennettP: International criteria for the diagnosis of diabetes and impaired glucose tolerance. Diabetes Care1985, 8: 562–567.
14.
SmithiesO: Zone electrophoresis in starch gels: Grouped variations in the serum proteins of normal human adults. Biochem J1955, 61: 629–641.
15.
AllainCPoonLChanC: Enzymatic determination of total cholesterol. Clin Chem1974, 20: 470–475.
16.
BucoloGDavidH: Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem1973, 19: 476–482.
17.
Lopes-VirellaMStonePEllisSColwellJ: Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem1977, 23: 882–884.
18.
FriedewaldWLevyRFredericksonD: Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem1972, 18: 499–509.
19.
RosseneuMVercaemstRVinaimontNVan TornoutPHendersonLHerbertP: Quantitative determination of the human plasma apolipoprotein Al by immunonephelometry. Clin Chem1981, 27: 856–859.
20.
RosseneuMVinaimontNMuslinerTBernierDHerbertPBelpaireF: Immunonephelometry of apolipoprotein All in plasma. Clin Chem1984, 30: 234–237.
21.
RosseneuMVinaimontNVercaemstRDe KeersgieterWBelpaireF: Standardisation of immunoassays for the quantitation of plasma apoB protein. Anal Biochem1981, 116: 204–210.
22.
LabeurCMichielsGBuryJUsherDRosseneuM: Quantitation of human lipoprotein Lp(a) by an enzyme-linked immunosorbent assay with monoclonal antibodies. Clin Chem1989, 35: 1380–1384.
23.
TownMGehmSHammerBZiegenhornJ: A sensitive method for the enzymatic determination of uric acid [letter]. J Clin Chem Clin Biochem1985, 23: 591.
24.
FinkPRoemerMHaeckelRFateh-MoghadamDelanghe JGressnerA: Measurement of proteins with the Behring nephelometer. J Clin Chem Clin Biochem1989, 27: 261–276.
25.
MaesMDelangheJScharpéSMeltzerHCosynsPSuyE: Haptoglobin phenotypes and gene frequencies in unipolar major depression. Am J Psychiatry1994, 151: 112–116.
26.
SwalesJBingRHagerthyAPohlJRussellGThurstonH: Treatment of refractory hypertension. Lancet1982, i:894–896.
27.
FrohlichE: Classification of resistant hypertension. Hypertension1988, 11 (suppl II):II67–II70.
28.
ModanMAlmogSFuchsZChetritALuskyAHalkinH: Obesity, glucose intolerance, hyperinsulinemia, and response to antihypertensive drugs. Hypertension1991, 17: 565–573.
29.
YakovlevitchMBlackH: Resistant hypertension in a tertiary care clinic. Arch Intern Med1991, 151: 1786–1792.
CollinsPBurmanJChungHFoxK: Hemoglobin inhibits endothelium-dependent relaxation to acetylcholine in human coronary arteries in vivo. Circulation1993, 87: 80–85.
32.
CidMGrantDHoffmanGAuerbachRFauciAKleinmanH: Identification of haptoglobin as a factor in sera from patients with systemic vasculitis.)Clin Invest1993, 91: 977–985.
33.
ChapelleJPAlbertASmeetsJHeusghemCKulbertusH: Effect of the haptoglobin phenotype on the size of a myocardial infarct. N Engl J Med1982, 307: 457–463.
34.
BowmanBYangF: DNA sequencing and chromosomal locations of human plasma protein genes. In The Plasma Proteins, vol V, 2nd edn. Edited by PutnamF.Orlando: Academic Press; 1987: 1–48.
35.
KöhlerWProkopO: Relationship between haptoglobin and Streptococcus pyogenes T4 antigens [letter]. Nature1978, 271:373.
36.
JueDShimBKangY: Inhibition of prostaglandin synthetase activity of sheep seminal vesicular gland by human serum haptoglobin. Mol Cell Biochem1983, 51: 141–147.
37.
Rantapaa DahlqvistSFröhlanderN: Haptoglobin groups and rheumatoid arthritis. Hum Hered1985, 35: 207–211.
